First- and Second-Line Treatments for Patients with Advanced Hepatocellular Carcinoma in China: A Systematic Review

Chinese national guidelines recommend various systemic therapies for patients with advanced hepatocellular carcinoma (HCC), but optimal treatment selection remains uncertain. To summarize the evidence supporting the systemic treatment of Chinese patients with advanced HCC, we performed a systematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lan, Sun, Junhui, Wang, Kui, Zhao, Haitao, Zhang, Xijie, Ren, Zhenggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600684/
https://www.ncbi.nlm.nih.gov/pubmed/36290852
http://dx.doi.org/10.3390/curroncol29100575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600684/
https://www.ncbi.nlm.nih.gov/pubmed/36290852
http://dx.doi.org/10.3390/curroncol29100575

Ejemplares similares